TAVR was associated with early benefits for women. After five years, however, outcomes were comparable across the board.

“We have colonoscopies, we have mammograms, but we have not had equivalents for most forms of heart disease,”  Pierre Elias, MD, Pathway Labs founder and CEO, explained.

When CMS shared a list of cardiologists being targeted with a brand new payment model, the American College of Cardiology identified a long list of apparent mistakes.

The newly cleared software alerts clinicians when it detects a suspected vascular occlusion.

Medaxiom CEO Jerry Blackwell, MD, MBA, FACC, discusses investor's interest in buying cardiology practices, noting that PE ownership remains relatively low.

One of the platform's biggest benefits is the rich clinical information it provides to all members of the care team.

Specific lots of several procedure kits have been recalled after the FDA identified quality issues during a recent inspection.

The self-expanding A-Flux device is implanted in the coronary sinus to increase pressure on the venous side of the heart and improve perfusion in smaller vessels.

Eight reports of major bleeding have been reported from Impella introducers, prompting the FDA early alert this week. 

Treating certain high-risk PCI patients with nicorandil before and after treatment can significantly reduce their risk of contrast-related injuries.